RecruitingNCT07075731
Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy
Sponsor
University of Minnesota
Enrollment
40 participants
Start Date
Jun 30, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to quantify the rates of cervical cancer screening and endometrial sampling prior to gender-affirming hysterectomy, assess the need for these tests in TGD individuals, and explore patient-centered options for these tests. By assessing the status of testing and correlation with hysterectomy pathology, this study will provide preliminary data on the current state of guideline-concordant care and provide initial evidence for the development of evidence-based guidelines in the future
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- years and older
- Able to provide voluntary written consent prior to the performance of any research related activity. Patients who can provide informed consent
- Able to understand, speak, read, and write in English
- Patients who have undergone hysterectomy, or plan to have a hysterectomy
- Patients who are transgender and gender diverse"
Exclusion Criteria5
- Opted out of research
- \<18 years old
- Lacks capacity to consent/has diminished capacity to consent
- Cannot provide informed consent
- Those on the study's community advisory board
Interventions
OTHERNo intervention
Observational study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07075731
Related Trials
Liquid Biopsy-Based Pre-Screening to Streamline LDCT Lung Cancer Screening in High-Risk Individuals
NCT073587151 location
Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis
NCT068224134 locations
Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk and Diagnosis and Treatment
NCT066534781 location
Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women
NCT052986052 locations
Artificial Intelligence System for Assessment of Tumor Risk and Diagnosis and Treatment
NCT054261351 location